Mandatory 8-hour fasting for solids and liquids. Complete metabolic panel, CBC, ECG, and anesthesia clearance. Psychological assessment and pre-operative nutritional counseling. Prophylactic antibiotics and venous thromboembolism (VTE) prophylaxis administered 60 minutes pre-incision.
Post-operative admission for 2 days for monitoring. Immediate commencement of liquid diet progression. Monitoring for early complications such as bleeding or perforation. Pain management and hydration monitoring. Discharge after clinical stability, ensuring adherence to the long-term liquid-to-soft diet plan.
Comprehensive Clinical Guide: Endoscopic Sleeve Gastroplasty (ESG) with Pyloric Sparing
1. Introduction and Overview
Endoscopic Sleeve Gastroplasty (ESG) with pyloric sparing represents a paradigm shift in the management of obesity and metabolic syndrome. As a minimally invasive, incisionless procedure, it bridges the gap between lifestyle modification/pharmacotherapy and traditional bariatric surgery (such as the Roux-en-Y gastric bypass or the laparoscopic sleeve gastrectomy).
By utilizing a specialized endoscopic suturing system, the procedure reduces the volume of the stomach by approximately 70-80%. Crucially, the "pyloric sparing" modification ensures that the natural outlet of the stomach remains untouched, preserving the physiological function of the pylorus. This maintains the natural transition of chyme into the duodenum, minimizing the risk of "dumping syndrome" and ensuring more physiological nutrient absorption compared to surgical bypass procedures.
2. Technical Specifications and Mechanism of Action
The Mechanism of Restriction
The primary goal of ESG is to create a restrictive gastric pouch that limits caloric intake through mechanical satiety. Unlike surgical gastrectomy, which involves the permanent excision of the greater curvature, ESG achieves this through the placement of full-thickness sutures within the stomach wall.
The Pyloric Sparing Advantage
The pylorus is the muscular valve that controls the emptying of the stomach into the small intestine. In traditional surgical sleeve gastrectomy, the distal stomach is often manipulated. In ESG with pyloric sparing:
* Preservation of Motility: The distal antrum and the pyloric sphincter are left entirely intact.
* Gastric Emptying: By preserving the pylorus, the patient maintains a more normal gastric emptying rate, which is associated with better tolerance of solid foods and reduced incidence of post-prandial hypoglycemia.
* Neuro-hormonal Impact: Preservation of the pyloric region maintains the integrity of the vagal innervation, which is vital for satiety signaling.
The Procedure Mechanics
- Endoscopic Access: The surgeon uses a dual-channel endoscope equipped with a suturing device (e.g., Apollo OverStitch).
- Suture Pattern: A series of stitches are placed along the greater curvature, starting from the incisura angularis and moving proximally toward the fundus.
- Tissue Plication: As the sutures are cinched, the gastric wall is folded inward, creating a narrow, tube-like structure.
- Verification: Air insufflation is used to confirm the tubular shape and ensure the lumen is significantly narrowed.
3. Clinical Indications and Patient Selection
The candidate for ESG is typically one who has failed to achieve significant weight loss through non-surgical means but may not meet the strict BMI criteria for traditional bariatric surgery, or who prefers to avoid the risks associated with general surgery.
Table 1: Patient Eligibility Criteria
| Criterion | Standard Requirement |
|---|---|
| Body Mass Index (BMI) | 30.0 – 45.0 kg/m² |
| Previous Attempts | Documented failure of supervised weight loss programs |
| Comorbidities | T2DM, Hypertension, Dyslipidemia, OSA |
| Age | 18 – 70 years |
| Psychological Status | Stable, motivated, and free of active eating disorders |
Contraindications
- Absolute: Pregnancy, active peptic ulcer disease, large hiatal hernia (>3cm), history of prior gastric surgery, or active gastrointestinal bleeding.
- Relative: Severe gastroesophageal reflux disease (GERD), chronic use of NSAIDs or anticoagulants, and severe cardiovascular disease.
4. Pre-Operative Preparation Protocol
Preparation is multidisciplinary, involving nutritionists, psychologists, and gastroenterologists.
- Nutritional Assessment: A 2-week pre-operative liquid-based diet is often prescribed to reduce liver volume and improve surgical visualization.
- Endoscopic Evaluation: A diagnostic EGD (Esophagogastroduodenoscopy) is mandatory to rule out hiatal hernias, gastric polyps, or gastritis.
- Medical Clearance: Cardiac risk stratification for patients with high-risk comorbidities.
- Medication Management: Cessation of blood thinners (e.g., Warfarin, Clopidogrel) per cardiologist/gastroenterologist guidance.
5. Post-Operative Recovery and Protocol
Recovery from ESG is significantly faster than surgical alternatives, with most patients returning to work within 3–5 days.
The Phased Diet Protocol
- Days 1–3: Clear liquids only (water, broth, diluted juice).
- Days 4–14: Full liquid diet (protein shakes, strained soups).
- Weeks 3–4: Pureed foods.
- Week 5+: Soft foods transitioning to a healthy, balanced diet.
Long-term Follow-up
- Month 1, 3, 6, 12: Clinical assessments to monitor weight loss, nutritional markers (B12, Iron, Vitamin D), and metabolic parameters.
- Behavioral Support: Ongoing engagement with an RD (Registered Dietitian) is the strongest predictor of long-term success.
6. Risks and Complications
While ESG is considered very safe, it is an invasive procedure and carries specific risks.
Potential Complications
- Post-Procedural Pain: Most patients experience mild to moderate abdominal cramping and nausea for 48–72 hours.
- Gastric Leak: Extremely rare (<0.5%), but requires immediate intervention.
- Bleeding: Minor mucosal bleeding can occur at suture sites.
- Suture Failure: In a small percentage of patients, the sutures may lose tension over time, leading to a decrease in restrictive efficacy.
7. Alternative Treatments
| Treatment Type | Mechanism | Invasiveness |
|---|---|---|
| Pharmacotherapy | GLP-1 Agonists (e.g., Wegovy) | Non-invasive |
| Intragastric Balloon | Space-occupying device | Minimally invasive |
| Laparoscopic Sleeve | Surgical resection of stomach | Highly invasive |
| Gastric Bypass | Resection + Malabsorption | Highly invasive |
8. Frequently Asked Questions (FAQ)
1. How much weight can I expect to lose?
Patients typically lose 15–20% of their total body weight within the first year, provided they adhere to the nutritional protocol.
2. Is the procedure reversible?
While technically possible to remove the sutures, ESG is generally considered a permanent intervention.
3. Will I need to take vitamins for the rest of my life?
Unlike surgical bypass, ESG does not cause malabsorption. However, daily multivitamins are recommended during the rapid weight loss phase to prevent deficiencies.
4. How long does the procedure take?
The actual endoscopic suturing typically takes 60 to 90 minutes.
5. Is ESG covered by insurance?
Coverage varies significantly by region and provider. Some insurers categorize it as "investigational," while others are beginning to cover it for patients with specific comorbidities.
6. What happens if I gain weight back?
If the stomach dilates over time, "revisionary" endoscopic procedures can sometimes be performed to tighten the sutures.
7. Does it affect my hunger hormones?
Yes. By reducing the volume of the fundus (where ghrelin is produced), ESG helps decrease hunger hormones, making it easier to stick to a caloric deficit.
8. Are there dietary restrictions after I heal?
You will be able to eat most foods, but you will experience "early satiety," meaning you will feel full much faster than before.
9. What is the difference between ESG and a traditional sleeve?
Traditional sleeve gastrectomy involves surgically removing 80% of the stomach. ESG is incisionless and preserves the entire anatomy of the stomach, just changing its shape.
10. Can I undergo this if I have acid reflux?
ESG is generally not recommended for patients with severe GERD, as the restrictive nature of the procedure can occasionally exacerbate reflux symptoms.
9. Conclusion: The Future of Metabolic Endoscopy
Endoscopic Sleeve Gastroplasty with pyloric sparing represents the gold standard in endobariatric medicine for patients seeking a significant, durable weight loss solution without the morbidity of major abdominal surgery. By maintaining the integrity of the pylorus and the gastric anatomy, it offers a physiological approach to weight management that aligns with modern trends toward minimally invasive, high-efficacy medical interventions.
As clinical data continues to accumulate, the role of ESG is expected to expand, potentially becoming a first-line therapy for early-stage metabolic syndrome and obesity-related comorbidities. Success, however, remains contingent on the patient's commitment to the post-procedural lifestyle modifications and the expertise of the interventional endoscopist performing the procedure.
Medical Disclaimer: This guide is for educational purposes only and does not constitute medical advice. Always consult with a board-certified bariatric surgeon or gastroenterologist to determine the best treatment plan for your specific health profile.